The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Algeta ASA; Aragon Pharmaceuticals; Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Biscayne Pharmaceuticals; Johnson & Johnson; Medivation; OncoGenex; Pfizer; Sanofi
Research Funding - Algeta ASA (Inst); Bayer (Inst); Johnson & Johnson (Inst); Progenics (Inst); Sanofi (Inst); Takeda (Inst)

Liver metastases in mCRPC patients post-therapy with abiraterone (Abi) and/or abiraterone/enzalutamide (Enza).
 
Lahiru Ranasinghe
No Relationships to Disclose
 
Patrick Cotogno
No Relationships to Disclose
 
Elisa M. Ledet
No Relationships to Disclose
 
Allie E. Steinberger
No Relationships to Disclose
 
Allison H. Feibus
No Relationships to Disclose
 
Kyle Degeyter
No Relationships to Disclose
 
Bruce Bordlee
No Relationships to Disclose
 
Oliver Sartor
No Relationships to Disclose